Back to Trades
Total Value
$6.6K
Net $6.6K sold
Filing Date
May 26, 2026
1 transaction
Sales
$6.6K
1 transaction
Trade Summary
On May 22, 2026, Pham Quang X, CEO and Chairman, Director, 10% Owner, sold $6.6K of Cadrenal Therapeutics, Inc. (CVKD) across 1 transaction. The filing covers Common Stock and reflects net selling of $6.6K. Reported prices ranged from $5.69. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Cadrenal Therapeutics, Inc.
- Ticker Symbol
- CVKD
- CIK
- 0001937993
Insider Information
- Name
- Pham Quang X
- Role
- CEO and Chairman, Director, 10% Owner
- Location
- PONTE VEDRA, FL
Filing Details
- Filing Date
- May 26, 2026
- Transaction Date
- May 22, 2026
- Accession Number
- 0001213900-26-061167
- Form Type
- 4
- Net Trading Amount
- -$6.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 22, 2026 | Common Stock | 1,165 | $5.69 | Sale | $6.6K |
Want live alerts when Pham Quang X trades again?
Download Insider Trades to track CVKD, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.60 through $5.82. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F3)Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and dispositive power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.